In lung cancer cells devoid of RhoB, the application of HDAC inhibitors led to increased expression of RhoB, highlighting the notion that HDACs epigenetically control RhoB expression, and thus play a role in tumorigenesis. This evidence concerns the gene HDAC9 and lung cancer.